Stock listing
B3:J2AZ34 Jazz Pharmaceuticals plc Ações
Brazilian listing (B3) of Jazz Pharmaceuticals plc · home listing NASDAQ:JAZZ
Follow Jazz Pharmaceuticals plc into a list and get an email when it puts out news.
Home listing price · NASDAQ:JAZZ
$214.44 USD -1.54 (-0.7%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:JAZZ
- Day range
- $213.81 – $218.36 USDNov 2, 2026
- Volume
- 1.04M sharesNov 2, 2026
- Market cap
- $13.92B USDAt the close on Nov 2, 2026 · price × 64.91M shares outstanding
- 52-week range
- $128.80 – $266.38 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $214.3M USDMedian day 773,557 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:JAZZ · Home | $214.44 USD | -1.54 (-0.7%) | 1,037,126 | $215.84 | $218.36 | $213.81 | $215.98 | Close on Nov 2, 2026 |
| Frankfurt:J7Z | €192.90 EUR | +7.40 (+4.0%) | — | €184.20 | €192.90 | €184.20 | €185.50 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:JAZZ · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $214.44 | -1.54 | -0.7% | $215.84 | $218.36 | $213.81 | 1,037,126 | |
| $215.98 | +8.15 | +3.9% | $209.63 | $216.38 | $209.36 | 1,212,681 | |
| $207.83 | +2.77 | +1.4% | $207.00 | $211.32 | $205.73 | 773,557 | |
| $205.06 | -1.72 | -0.8% | $204.38 | $206.77 | $202.30 | 816,104 | |
| $206.78 | +1.08 | +0.5% | $206.31 | $207.67 | $204.04 | 605,810 | |
| $205.70 | -8.30 | -3.9% | $215.29 | $216.43 | $205.11 | 969,992 | |
| $214.00 | -0.65 | -0.3% | $213.09 | $215.35 | $211.49 | 560,601 | |
| $214.65 | +2.68 | +1.3% | $211.38 | $215.24 | $210.26 | 783,806 | |
| $211.97 | -1.79 | -0.8% | $213.75 | $215.13 | $211.53 | 695,908 | |
| $213.76 | +5.33 | +2.6% | $209.89 | $215.55 | $208.98 | 663,267 | |
| $208.43 | -1.80 | -0.9% | $209.60 | $210.57 | $206.71 | 716,947 | |
| $210.23 | -4.19 | -2.0% | $214.25 | $214.78 | $208.15 | 636,700 | |
| $214.42 | +4.77 | +2.3% | $212.19 | $217.57 | $212.19 | 886,400 | |
| $209.65 | -0.74 | -0.4% | $210.34 | $215.66 | $209.36 | 891,300 | |
| $210.39 | -6.36 | -2.9% | $216.86 | $216.86 | $209.34 | 812,600 | |
| $216.75 | -1.67 | -0.8% | $218.90 | $221.99 | $216.57 | 739,600 | |
| $218.42 | -4.03 | -1.8% | $221.79 | $227.00 | $213.20 | 1,288,300 | |
| $222.45 | -8.74 | -3.8% | $228.55 | $229.33 | $214.68 | 1,268,600 | |
| $231.19 | -0.20 | -0.1% | $229.62 | $235.54 | $227.00 | 578,900 | |
| $231.39 | -4.65 | -2.0% | $236.40 | $236.40 | $228.70 | 862,200 | |
| $236.04 | +0.37 | +0.2% | $235.51 | $238.87 | $234.12 | 844,600 | |
| $235.67 | +2.66 | +1.1% | $233.40 | $237.77 | $231.70 | 636,600 | |
| $233.01 | +1.49 | +0.6% | $230.33 | $234.47 | $229.85 | 740,600 | |
| $231.52 | -0.83 | -0.4% | $231.60 | $236.00 | $230.39 | 1,001,900 | |
| $232.35 | -5.93 | -2.5% | $236.30 | $238.00 | $229.16 | 777,200 | |
| $238.28 | +0.33 | +0.1% | $235.67 | $238.83 | $234.63 | 788,300 | |
| $237.95 | +1.67 | +0.7% | $239.12 | $239.12 | $235.66 | 1,129,600 | |
| $236.28 | +1.40 | +0.6% | $235.82 | $236.52 | $232.00 | 551,300 | |
| $234.88 | -5.69 | -2.4% | $239.26 | $241.33 | $231.59 | 792,200 | |
| $240.57 | -0.89 | -0.4% | $242.01 | $243.21 | $239.78 | 482,000 | |
| $241.46 | +0.72 | +0.3% | $240.87 | $244.49 | $238.53 | 499,200 | |
| $240.74 | -3.10 | -1.3% | $244.55 | $244.55 | $238.98 | 2,214,700 | |
| $243.84 | +0.25 | +0.1% | $246.59 | $247.31 | $243.57 | 569,600 | |
| $243.59 | +2.76 | +1.1% | $242.93 | $244.36 | $241.76 | 602,200 | |
| $240.83 | -5.04 | -2.0% | $246.81 | $246.81 | $239.84 | 702,600 | |
| $245.87 | +0.07 | 0.0% | $247.68 | $248.45 | $244.66 | 465,400 | |
| $245.80 | +5.32 | +2.2% | $244.60 | $246.73 | $244.04 | 422,900 | |
| $240.48 | -0.83 | -0.3% | $240.94 | $244.46 | $239.29 | 1,029,500 | |
| $241.31 | +1.24 | +0.5% | $238.38 | $241.44 | $236.00 | 424,500 | |
| $240.07 | -6.74 | -2.7% | $240.00 | $244.71 | $239.11 | 467,900 | |
| $246.81 | -0.76 | -0.3% | $246.00 | $249.00 | $244.75 | 321,900 | |
| $247.57 | +2.00 | +0.8% | $246.92 | $248.91 | $241.87 | 507,600 | |
| $245.57 | +1.86 | +0.8% | $244.00 | $248.07 | $241.02 | 1,155,900 | |
| $243.71 | -6.97 | -2.8% | $250.13 | $252.50 | $243.02 | 1,072,800 | |
| $250.68 | +6.14 | +2.5% | $241.39 | $252.72 | $241.39 | 1,221,000 | |
| $244.54 | -6.56 | -2.6% | $249.48 | $250.64 | $244.49 | 1,192,900 | |
| $251.10 | +1.81 | +0.7% | $250.00 | $252.85 | $246.99 | 4,740,300 | |
| $249.29 | -10.94 | -4.2% | $257.40 | $259.83 | $248.52 | 2,373,000 | |
| $260.23 | +5.76 | +2.3% | $256.36 | $266.38 | $254.59 | 1,560,100 | |
| $254.47 | +0.19 | +0.1% | $253.66 | $254.70 | $250.44 | 419,900 | |
| $254.28 | +5.58 | +2.2% | $248.75 | $255.85 | $248.55 | 516,600 | |
| $248.70 | -3.46 | -1.4% | $249.60 | $254.93 | $245.76 | 439,900 | |
| $252.16 | -0.91 | -0.4% | $255.65 | $256.92 | $251.26 | 549,500 | |
| $253.07 | +4.71 | +1.9% | $248.73 | $256.41 | $248.73 | 459,200 | |
| $248.36 | +3.40 | +1.4% | $244.00 | $248.52 | $243.16 | 504,900 | |
| $244.96 | -0.89 | -0.4% | $243.59 | $245.35 | $240.63 | 542,000 | |
| $245.85 | -3.10 | -1.2% | $251.38 | $251.38 | $243.74 | 468,000 | |
| $248.95 | +0.97 | +0.4% | $246.38 | $251.92 | $244.35 | 553,500 | |
| $247.98 | -8.54 | -3.3% | $257.16 | $257.16 | $246.48 | 1,288,300 | |
| $256.52 | -0.04 | 0.0% | $256.95 | $261.28 | $255.54 | 896,500 | |
| $256.56 | -0.09 | 0.0% | $257.49 | $258.38 | $254.69 | 970,700 | |
| $256.65 | -4.92 | -1.9% | $262.44 | $264.03 | $255.69 | 804,500 | |
| $261.57 | -0.05 | 0.0% | $262.90 | $265.05 | $258.65 | 715,300 | |
| $261.62 | +10.04 | +4.0% | $255.39 | $262.00 | $247.42 | 1,895,100 | |
| $251.58 | -1.28 | -0.5% | $255.22 | $255.22 | $248.45 | 1,493,300 |
- Ticker
- B3:J2AZ34
- Asset type
- Stock
- Exchange
- B3
- Currency
- BRL
What changed lately
Latest news release · Nov 2, 2026
Jazz Pharmaceuticals Announces Third Quarter 2026 Financial Results
Latest earnings call · Nov 2, 2026
Jazz Pharmaceuticals (NASDAQ:JAZZ) Q3 2026 Earnings Call
Replay and transcript
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 27 slides
Calls
Replays
Jazz Pharmaceuticals (NASDAQ:JAZZ) Q3 2026 Earnings Call
Mon, Nov 02, 2026 · 4:30 PM ET
Watch TranscriptJazz Pharmaceuticals (NASDAQ:JAZZ) Q2 2026 Earnings Call
Mon, Aug 03, 2026 · 4:30 PM ET
Watch TranscriptJazz Pharmaceuticals (NASDAQ:JAZZ) Q1 2026 Earnings Call
Tue, May 05, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Ziihera® (zanidatamab-hrii) Combinations Demonstrate Sustained Survival at Three Years in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma at ESMO 2026
Oct 23, 2026
Closed $214.00 (-0.3%) on Oct 23, 2026
Jazz Pharmaceuticals to Report Third Quarter Financial Results on November 2, 2026
Oct 19, 2026
Closed $213.76 (+2.6%) on Oct 20, 2026
Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences
Sep 15, 2026
Closed $240.83 (-2.0%) on Sep 15, 2026
Ziihera® (zanidatamab-hrii) plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Versus Trastuzumab plus Chemotherapy in First-Line HER2+ Advanced GEA
Aug 31, 2026
Closed $250.68 (+2.5%) on Aug 31, 2026
Jazz Pharmaceuticals Announces Pricing of Upsized Private Offering of $1.1 Billion of 1.875% Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases
Aug 27, 2026
Closed $251.10 (+0.7%) on Aug 27, 2026
Jazz Pharmaceuticals Announces Private Offering of $1.0 Billion of Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases
Aug 26, 2026
Closed $249.29 (-4.2%) on Aug 26, 2026
Jazz Pharmaceuticals to Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio
Aug 10, 2026
Closed $256.52 (0.0%) on Aug 10, 2026
Jazz Pharmaceuticals Announces Second Quarter 2026 Financial Results
Aug 3, 2026
Closed $261.62 (+4.0%) on Aug 4, 2026
Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026
Jul 20, 2026
Closed $254.22 (+4.4%) on Jul 21, 2026
Financings
1.875% exchangeable senior notes due 2032
Aug 27, 2026
Made bigger: US$1.1B
Use of proceeds: General corporate purposes
Decks
Investor Presentation (September 2026)
Investor deck · 27 slides · September 2026
Corporate Update (August 2026)
Corporate update · 23 slides · Aug 25, 2026
Q2 2026 Earnings Presentation
Earnings · 25 slides · Aug 3, 2026
Q4 2025 Earnings Presentation
Earnings · 29 slides · Feb 24, 2026
Jazz Pharmaceuticals plc on 6ix
- News releases
- 40 in the last 12 months · 271 in all · newest Nov 2, 2026 · oldest 2019
- Calls
- 18 calls with a replay · 18 with a transcript · latest Nov 2, 2026
- Decks
- 37 decks · latest September 2026
Where Jazz Pharmaceuticals plc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:JAZZ · Home listing | NASDAQ | United States | USD |
| Tradegate:J7Z | Tradegate | Germany | EUR |
| gettex:J7Z | gettex | Germany | EUR |
| LS Exchange:A1JS1K | LS Exchange | Germany | EUR |
| Frankfurt:J7Z | Frankfurt | Germany | EUR |
| Lang & Schwarz:A1JS1K | Lang & Schwarz | Germany | EUR |
| BOATS:JAZZ | BOATS | United States | USD |
| Milan:1JAZZ | Milan | Italy | EUR |
| B3:J2AZ34 · This page | B3 | Brazil | BRL |
| BMV:JAZZN | BMV | Mexico | MXN |
| Stuttgart:J7Z | Stuttgart | Germany | EUR |
| BIVA:JAZZN | BIVA | Mexico | MXN |
| BX Swiss:J7Z | BX Swiss | Switzerland | CHF |
| Dusseldorf:J7Z | Dusseldorf | Germany | EUR |
| Hamburg:J7Z | Hamburg | Germany | EUR |
| Hanover:J7Z | Hanover | Germany | EUR |
| Munich:J7Z | Munich | Germany | EUR |
| Xetra:J7Z | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Jazz Pharmaceuticals plc.